ABSTRACT Fifty-six fibreoptic bronchoscopies were performed on 42 patients with Hodgkin's disease, lymphoma, or leukaemia and pulmonary complications which did not respond to conventional antibiotics. All these patients had received chemotherapy, radiotherapy, or both for the treatment of their underlying conditions. Twenty-two bronchoscopic procedures were complicated by thrombocytopenia and neutropenia, requiring platelet transfusion before bronchoscopy, and many patients were hypoxaemic. Visual examination of the tracheobronchial tree, alveolar lavage, bronchial brushing, and transbronchial biopsy were carried out as approximate. Three patients had minor pulmonary haemorrhage, and three developed a pneumothorax after transbronchial biopsy. A specific diagnosis was obtained in 14 of 18 patients (78%) with diffuse chest radiographic abnormalities, in seven of 11 patients (64%) with lobar or segmental (focal) abnormalities, in two of eight patients with small (local) lesions, and in three of five patients with hilar abnormalities. In only three patients were infections diagnosed. It is concluded that fibreoptic bronchoscopy is a useful and safe diagnostic procedure in this situation but its value depends upon the type of radiological abnormality.
It has long been recognised that pulmonary lesions occur frequently in patients with Hodgkin's disease, malignant lymphoma, and leukaemias, and that there are many possible causes. Such pulmonary complications may be the result of infection, either by the common bacterial organisms, by Mycobacterium tuberculosis, or by a wide variety of opportunistic pathogens which may invade lung tissue in patients who are immunocompromised as a result of their disease, of chemotherapy, or of radiotherapy.1 The more common of these opportunistic pathogens include .Pneumocystis carinii, Aspergillus, Nocardia, and certain viruses. Several surveys2 3 have shown that lung involvement in Hodgkin's disease is common, occurring in up to 43% of patients, and that in addition the pleura, mediastinum or hilar nodes may be affected. Lung involvement may also occur in malignant lymphomas and in leukaemias. 4 5 Separate neoplastic diseases of the lung may also be found with increased frequency in this group of patients, especially when rendered immuno-deficient by cytotoxic agents or radiotherapy. 6 Chemotherapy and radiotherapy may themselves produce a pneumonitis with pulmonary shadowing, the signs and symptoms of which are indistinguishable from those resulting from infective causes.7 8 Finally it has been suggested9 that occult pulmonary haemorrhage is a more common cause of pulmonary infiltration in thrombocytopenic immuno-compromised patients than had been thought previously.
Pulmonary complications are a frequent cause of morbidity or death in this group of patients. A proportion of the causes are susceptible to treatment, and it is important to make a specific diagnosis because of the wide range of possible causes and the toxicity of many of the drugs used in their treatment. Clinical signs and symptoms and chest radiographic appearances have proved to be poor indicators of the cause of lung shadowing. Examination The patients fasted for at least four hours before the procedure and were given a premedication with omnopon and either scopolamine or atropine one hour before bronchoscopy. In thrombocytopenic patients the premedication was given intravenously at the time of the procedure. The bronchoscope was passed transnasally into the trachea after lignocaine administration into the nose and oropharynx. 16 Once the trachea had been entered, a trap was inserted into the suction line to collect any secretions or washings, and the bronchoscope was advanced further into the tracheobronchial tree with administration of 2% lignocaine to prevent and control coughing. In the two patients who were venti'lated, the bronchoscope was passed directly into the trachea via an endotracheal tube through a connector that provides an airtight seal. '7 A visual examination of the bronchial tree was made in each case and any endobronchial lesions biopsied. If no endobronchial lesion was visible, samples were taken from the affected area under single plane fluoroscopic control. Where appropriate a Medi-Tech sheathed cytology brush'8 was inserted into the affected area of the lung, and cell debris and secretion collected and placed immediately on to bacteriology plates for aerobic and anaerobic culture, fungal and mycobacterial culture. The tip of the brush was cut off and incubated in thioglycolate for anaerobic organisms.
Alveolar washings were performed with 50-100 ml of sterile saline which were instilled into a segmental bronchus on inspiration and aspirated during expiration. The localised type of lesion to a more diffuse lung involvement over a longer period. A positive diagnosis was achieved in three of these four, in one of whom two different causes were established on the two occasions. In a further three patients FOB was performed on three occasions within a relatively short period of time, but no evidence of infection or pulmonary involvement by the disease process was found. One of these patients, who had thrombocytopenia, probably had a pulmonary haemorrhage as numerous haemosiderin-laden macrophages were seen, and one patient was found at postmortem to have had pulmonary oedema secondary to a large aortic thrombus. Overall a positive diagnosis was made in 14 (78%) of these patients, and infection as a cause was almost certainly excluded in a further three. The results of FOB influenced treatment in 11 patients (61%) but mortality remained very high, 14 patients (77 8%) dying within three months, most within the first two weeks. Of the four patients who survived for between eight and 24 months, treatment was undoubtedly influenced by FOB.
FOCAL RADIOGRAPHIC CHANGES
Eleven patients had segmental or lobar involvements of the lung which were designated as "focal" pulmonary lesions. A positive diagnosis was made in seven cases (63 6%). The diagnoses obtained are shown in table 2. In one patient the initial diagnosis of Hodgkin's disease was changed to lymphomatoid granulomatosis on the basis of the histological samples obtained by FOB. Where a diagnosis was not achieved three patients probably had pulmonary involvement with Hodgkin's disease as judged by their subsequent clinical course. In the other undiagnosed patient histology showed some of the macrophages to have formed foreign-body-type giant cells, the significance of which remained uncertain. There was, however, no evidence of an infective aetiology for the pulmonary lesion. Where a diagnosis was obtained treatment was influenced in each case, with improvement in four patients. A patient with squamous cell carcinoma received conservative therapy. Two other patients, in whom a diagnosis was not made, died and permission for necropsy was refused. Survival times for the remainder varied between 10 and 28 months.
LOCAL RADIOGRAPHIC CHANGES
Eight patients had small pulmonary lesions of less than 3 cm diameter. In one of these patients the lesion progressed undiagnosed to diffuse involvement for which a further FOB was performed. This established pulmonary infiltration with Hodgkin's disease, the latter result being included in the group with diffuse changes. A positive diagnosis was made in two patients (table 2). In this group all patients had Hodgkin's disease and the undiagnosed lesion probably constituted local involvement with this condition. Most of these patients subsequently received chemotherapy with resolution of the lesions and all have remained alive for between nine and 29 months.
HILAR RADIOGRAPHIC CHANGES
Five patients had a prominent hilum or definite hilar abnormality. A diagnosis of Hodgkin's disease was made in two by FOB. One patient had a prominent hilum and was dyspnoeic. No endobronchial lesion was seen but biopsy of the bronchial mucosa showed the changes of asthma and this fitted in with the clinical picture: she responded to normal therapy for asthma. In the two cases where diagnoses were not obtained the hilar changes were probably the results of glandular involvement by lymphoma, and these patients later received chemotherapy and improved. Our results compare well with other published series on immuno-compromised patients. Cunningham et aP21 obtained a specific diagnosis in 48% of transbronchial biopsy procedures combined with bronchial brushing and 65% of percutaneous trephine lung biopsies. When a diagnosis of nonspecific interstitial pneumonitis was included the yield rate rose to 74% and 82% respectively. Matthay et al'6 obtained a specific diagnosis in 10 out of 11 (91%) focal lesions and 11 out of 14 (78 6%) diffuse lesions using combined bronchial brushing and TBB. A considerably lower yield is obtained if bronchial brushing alone is employed, varying from 28%8 to 63%. 16 In the initial phase of the study we repeated the procedure for a second or even third time in those patients where TBB revealed nonspecific changes. We found these repeat procedures unhelpful in that they did not provide further information, and the patients' later progress did not suggest that any treatable condition had been missed. However repeat TBB was of value in three cases where the tissue was histologically normal in the first instance indicating that it had not come from the appropriate lesion.
Several transbronchial biopsies showed nonspecific histology with no evidence of any infective aetiology. In three patients a dense fibrinous exudate was found with evidence of damage to the alveoli. This may have resulted from cytotoxic therapy but might represent an organising pneumonic process in a patient without adequate granulocytic function and hence without the normal methods of removing the intra-alveolar exudate.
The diagnosis of pulmonary haemorrhage has been made on the basis of numerous haemosiderinladen macrophages found in the alveolar lavage, at a time when there had been no overt haemorrhage or other cause of bleeding apart from thrombocytopenia. The diagnosis was made in three patients all of whom had diffuse radiographic shadowing and thrombocytopenia. The diagnosis was confirmed by necropsy findings in one patient and supported by histology from transbronchial biopsy in another. Recently Drew et a19 have suggested that occult pulmonary haemorrhage may be more common in thrombocytopenic immunocompromised patients than has been recognised hitherto, and they reported nine out of 12 consecutive patients who had this problem. In our series we found evidence of pulmonary haemorrhage in only three patients out of 15 who were thrombocytopenic.
One of the striking features in our series is the relative lack of bacterial or other opportunistic pathogens as aetiological agents for the pumonary lesions. This is in sharp contrast to other studies where the most common diagnosis was infection, whether caused by bacteria, Pneumocystis carinii, fungi, or more rarely viruses.8 10 11 16 21 Most of these studies are from the USA where fungal infections are in general more frequent than in Britain. In addition the difference may be the result of some selection in the patients coming to FOB because a policy had been adopted of treating with broad spectrum antibiotics all pyrexial patients with focal or diffuse pulmonary lesions. Those in whom resolution or improvement of their lesions did not occur were referred for bronchoscopy. Several patients who were suspected clinically of having Pneumocystis carinii were treated with high doses of co-trimoxazole with subsequent resolution of the pulmonary lesions. The series was thus biased away from simple infective causes. Probably as a consequence of this we found that most of our information was derived from histology of the transbronchial biopsy specimens and cytological examination of bronchial brushings, and that little additional information was forthcoming from selective cultures with a sheathed brush. Alveolar lavage was helpful more for cytological examination than for bacteriology. Even when simple bacteria were isolated there were often difficulties of interpretation because of the problems of contamination of the bronchoscope by oropharyngeal organisms, and this was not avoided entirely by the use of sheathed brushes which may also become contaminated during their passage down the lumen of the bronchoscope.
Haemorrhage as a result of transbronchial biopsy was not a problem in our series even in those patients who were thrombocytopenic. This was presumably attributable to our policy of giving fresh donor platelet transfusions to all patients who had a platelet count of less than 60000. However, none of our patients was significantly uraemic which may also have contributed to the lower incidence of haemorrhage, as it is known that this predisposes to bleeding. 2' 22 The only other complications found in this series were three pneumothoraces, one of which occurred in a patient who was being ventilated because of severe hypoxaemia. In the other two patients the pneumothorax was asymptomatic but one received intercostal drainage in view of the degree of collapse of the lung.
Thus FOB and TBB appear to be relatively safe techniques in the investigation of immunocompromised patients with pulmonary complications, despite the presence of thrombocytopenia and arterial hypoxaemia, providing platelet transfusions and supplemental oxygen are administered.
In general, other invasive procedures have provided yield rates that are no better and often worse than FOB, but in addition are associated with a greater morbidity. Thus open lung biopsy in this situation has given specific diagnoses of 79%1" and 71%12 but with the discomfort and morbidity associated with operation. Needle aspiration biopsies give generally lower yields of between 60% and 73%, and pulmonary haemorrhage has been reported to occur in 8%,1o1" with an 8-30% incidence of pneumothoraces.10 23 Cutting needle biopsies may give yields of up to 75%10 but not only have a high incidence of pneumothoraces, but in this type of patient carry a real risk of haemorrhage which is difficult to controlGreenman et al'0 reported a 15% incidence of haemorrhage with this technique. Trephine drill biopsies may provide good samples of lung for histology and Cunningham et a12' were able to obtain a specific diagnosis in 65% of cases, but this procedure had a 60% incidence of pneumothorax and a 17% incidence of haemorrhage.
Fibreoptic bronchoscopy offers the advantages of more satisfactory control of any haemorrhage which occurs by the local instillation of adrenaline solutions and by using the "wedge" technique as described by Zavala14 to act as a tamponade. There has been no recorded fatality from TBB in this situation, although this has occurred with the use of the cutting needle biopsy technique.10 The incidence of pneumothoraces is much lower than with the use of percutaneous techniques, and it is possible to sample parenchyma from a variety of sites as well as collect bronchial secretions and diagnose endobronchial lesions.
Although a specific diagnosis was made in a high percentage of patients with diffuse disease, the clinical outcome remained poor with only four out of 18 surviving in this group. One of these patients had infiltration with lymphoma and one with Hodgkin's disease; both responded to chemotherapy. The other two had cytotoxic lung. In general, immuno-compromised patients with diffuse pulmonary disease are in a precarious state, so that a poor prognosis is not unexpected, but the circumstances may be particularly unfavourable in our group because of the bias away from simple infective causes. Only those patients who had not responded to antibiotics were selected for bronchoscopy and thus included in this series. Although many of the patients proved to be unresponsive to further treatment, a diagnosis was still helpful in providing a more rational basis for management.
There was a more favourable outcome for those patients with other than diffuse lesions. There was a good diagnostic yield in the group with focal lesions, and this unquestionably influenced further management. Eight out of the 11 patients in this group remain alive. All patients with hilar abnormalities had Hodgkin's disease or non-Hodgkin's lymphoma, and most received chemotherapy or radiotherapy with subsequent resolution. All are still alive.
We achieved a poor diagnostic success rate in patients with local lesions. All these patients had Hodgkin's disease but with little evidence of activity elsewhere. Many of the patients were asymptomatic and the lesions only came to notice on routine chest film. The disease, therefore, appeared to be in a more benign phase than in those patients with diffuse or focal changes, and this is reflected in the fact that all patients in this group remain alive. Most of the patients received further chemotherapy on the grounds that the likely diagnosis was lung infiltration with Hodgkin's disease, and indeed the lesions resolved or regressed on this treatment. Despite the poor yield rate from FOB in this category, this procedure may reveal other factors such as the unexpected diagnosis of adenocarcinoma in a patient whose chest film had no distinguishing features from others in the group.
We conclude that FOB has a useful role in the investigation of pulmonary lesions in the immunocompromised patient. In general the procedure is well tolerated and the morbidity is low, conferring an advantage over many of the alternative invasive techniques. The yield rate varies according to the type of pulmonary lesions, being most successful in patients with diffuse or focal radiographic changes where it compares very favourably with other techniques. Despite the fact that our yield with local lesions was poor we still believe that FOB should remain the invasive procedure of first choice whatever the type of pulmonary lesion. Although the final outcome is frequently poor, a proportion of patients are unquestionably helped by a definitive diagnosis, and the management of the remainder is put on a more rational basis.
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